![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/eirgenixs-breast-cancer-biosimilar-receives-marketing-authorization-by-ec-301996431.html
https://www.prnewswire.com/news-releases/eirgenixs-second-breast-cancer-biosimilar-eg1206a-successfully-reaches-phase-1-clinical-trial-objectives-301813987.html
https://www.prnewswire.com/news-releases/positive-phase-iii-clinical-results-for-eirgenixs-proposed-trastuzumab-biosimilar-301255022.html
https://www.fiercebiotech.com/biotech/ireland-s-shorla-nabs-8-3m-to-bring-improved-cancer-meds-to-u-s